The American pharmaceutical company Eli Lilly will invest 250 million euros next year to create a new center for the production of insulin in Sesto Fiorentino, in Tuscany. The French newspaper "Les Echos" writes it, explaining that so far a large part of Eli Lilly's insulin production came from the Fegersheim plants, near Strasbourg (France) but, given the continuous growth in demand, it became necessary to expand production capacity
The Journal of 12/28/2007 ed. national p. 26
